Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: May 29, 2023. (Total: 217385Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Neuroblastoma and HLA-G[original query]
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine 2008 May 358 (18): 1909-18.
Schlenk Richard F, Döhner Konstanze, Krauter Jürgen, Fröhling Stefan, Corbacioglu Andrea, Bullinger Lars, Habdank Marianne, Späth Daniela, Morgan Michael, Benner Axel, Schlegelberger Brigitte, Heil Gerhard, Ganser Arnold, Döhner Hartmut,
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Dec 15 (23): 7330-4.
Venstrom Jeffrey M, Zheng Junting, Noor Nabila, Danis Karen E, Yeh Alice W, Cheung Irene Y, Dupont Bo, O'Reilly Richard J, Cheung Nai-Kong V, Hsu Katharine
Genotypes of NK cell KIR receptors, their ligands, and Fc? receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.
Cancer research 2010 Dec 70 (23): 9554-61.
Delgado David C, Hank Jacquelyn A, Kolesar Jill, Lorentzen David, Gan Jacek, Seo Songwon, Kim Kyungmann, Shusterman Suzanne, Gillies Stephen D, Reisfeld Ralph A, Yang Richard, Gadbaw Brian, DeSantes Kenneth B, London Wendy B, Seeger Robert C, Maris John M, Sondel Paul
Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Tissue antigens 2015 Sep 86 (3): 172-7.
Keating S E, Ní Chorcora C, Dring M M, Stallings R L, O'Meara A, Gardiner C
KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 07 34 (21): 2443-51.
Forlenza Christopher J, Boudreau Jeanette E, Zheng Junting, Le Luduec Jean-Benoît, Chamberlain Elizabeth, Heller Glenn, Cheung Nai-Kong V, Hsu Katharine
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 10 24 (1): 189-196.
Erbe Amy K, Wang Wei, Carmichael Lakeesha, Kim KyungMann, Mendonça Eneida A, Song Yiqiang, Hess Dustin, Reville Patrick K, London Wendy B, Naranjo Arlene, Hank Jacquelyn A, Diccianni Mitchell B, Reisfeld Ralph A, Gillies Stephen D, Matthay Katherine K, Cohn Susan L, Hogarty Michael D, Maris John M, Park Julie R, Ozkaynak M Fevzi, Gilman Andrew L, Yu Alice L, Sondel Paul
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.
Oncoimmunology 2018 9 7 (8): e1461305.
Modak Shakeel, Le Luduec Jean-Benoit, Cheung Irene Y, Goldman Debra A, Ostrovnaya Irina, Doubrovina Ekaterina, Basu Ellen, Kushner Brian H, Kramer Kim, Roberts Stephen S, O'Reilly Richard J, Cheung Nai-Kong V, Hsu Katharine
Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
PloS one 2022 17 (8): e0273280.
Przyby?a Weronika, Gjersvoll Paulsen Kirsti Marie, Mishra Charitra Kumar, Nygård Ståle, Engebretsen Solveig, Ruud Ellen, Trøen Gunhild, Beiske Klaus, Baumbusch Lars Oliv
TOP